Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats
Apoptosis in the myocardium is linked to ischemia/reperfusion injury, and TNF-alpha induces apoptosis in cardiomyocytes. A significant amount of TNF-alpha is detected after ischemia and reperfusion. Soluble TNF-alpha receptor 1 (sTNFR1) is an extracellular domain of TNF-alpha receptor 1 and is an an...
Gespeichert in:
| Veröffentlicht in: | Molecular and cellular biochemistry 2004-11, Vol.266 (1-2), p.127-132 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 132 |
|---|---|
| container_issue | 1-2 |
| container_start_page | 127 |
| container_title | Molecular and cellular biochemistry |
| container_volume | 266 |
| creator | Sugano, Masahiro Hata, Tomoji Tsuchida, Keiko Suematsu, Nobuhiro Oyama, Jun-Ichi Satoh, Shinji Makino, Naoki |
| description | Apoptosis in the myocardium is linked to ischemia/reperfusion injury, and TNF-alpha induces apoptosis in cardiomyocytes. A significant amount of TNF-alpha is detected after ischemia and reperfusion. Soluble TNF-alpha receptor 1 (sTNFR1) is an extracellular domain of TNF-alpha receptor 1 and is an antagonist to TNF-alpha. In the present study, we examined the effects of sTNFR1 on infarct size in acute myocardial infarction (AMI) following ischemia/reperfusion. Male Wistar rats were subjected to left coronary artery (LCA) ligation. After 30 min of LCA occlusion, the temporary ligature on the LCA was released and blood flow was restored. Immediately after reperfusion, a total of 200 microg of sTNFR1 or LacZ plasmid was injected into three different sites of the left ventricular wall. At 6 h, 1 and 2 days after reperfusion, the TNF-alpha bioactivity in the myocardium was significantly higher in rats receiving LacZ plasmid than in sham-operated rats, whereas sTNFR1 plasmid significantly suppressed the increase in the TNF-alpha bioactivity. The sTNFR1 plasmid significantly reduced DNA fragmentation and caspase activity compared to the LacZ plasmid. Finally, the sTNFR1 expression-plasmid treatment significantly reduced the area of myocardial infarction at 2 days after ischemia/reperfusion compared to LacZ plasmid. In conclusion, the TNF-alpha bioactivity in the heart increased from the early stage of ischemia/reperfusion, and this increase was thought to contribute in part to the increased area of myocardial infarction. Suppression of TNF-alpha bioactivity with the sTNFR1 plasmid reduced the infarct size in AMI following ischemia and reperfusion. |
| doi_str_mv | 10.1023/b:mcbi.0000049149.03964.c9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_815537569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>815537569</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-6330f7fb207e40bee50f7d1055566551ef5a42820fdd419e6ec7befeb3c87f603</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EokvhLyCrBzhl64ntOOmNrihUWuBSzpbjjFuvnDjYm6Ly6_HSlSpxgNFIoxk986WXkDNga2A1P-8vRtv7NTuY6EB0a8a7Rqxt94ysQCpelWr3nKwYZ6xqQakT8irnHWNQHF6SE5CNaBjnK3K_jdYEOmDw95geaHQ0x7D0AenN16vKhPnO0IQW531MFOgtTljyYbGYqZ-cSXZPs_-F1MUQ4k8_3VKf7R2O3pwnnDG5Jfs4FXa3lPl-osns82vywpmQ8c0xnpLvVx9vNp-r7bdP15sP28oKBfuq4Zw55fqaKRSsR5QlHYBJKZtGSkAnjajbmrlhENBhg1b16LDntlWufHhK3j_OnVP8sWDe67FchyGYCeOSdQtSciWbrpDv_kk2qoZadPy_YA3QqhZEAc_-AndxSVN5V5eNtVBK1gW6eIRsijkndHpOfjTpQQPTB7X1pf6yubzWT2rrP2pre7j57XHD0o84PLUe5eW_AZU4p48</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>756247752</pqid></control><display><type>article</type><title>Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Sugano, Masahiro ; Hata, Tomoji ; Tsuchida, Keiko ; Suematsu, Nobuhiro ; Oyama, Jun-Ichi ; Satoh, Shinji ; Makino, Naoki</creator><creatorcontrib>Sugano, Masahiro ; Hata, Tomoji ; Tsuchida, Keiko ; Suematsu, Nobuhiro ; Oyama, Jun-Ichi ; Satoh, Shinji ; Makino, Naoki</creatorcontrib><description>Apoptosis in the myocardium is linked to ischemia/reperfusion injury, and TNF-alpha induces apoptosis in cardiomyocytes. A significant amount of TNF-alpha is detected after ischemia and reperfusion. Soluble TNF-alpha receptor 1 (sTNFR1) is an extracellular domain of TNF-alpha receptor 1 and is an antagonist to TNF-alpha. In the present study, we examined the effects of sTNFR1 on infarct size in acute myocardial infarction (AMI) following ischemia/reperfusion. Male Wistar rats were subjected to left coronary artery (LCA) ligation. After 30 min of LCA occlusion, the temporary ligature on the LCA was released and blood flow was restored. Immediately after reperfusion, a total of 200 microg of sTNFR1 or LacZ plasmid was injected into three different sites of the left ventricular wall. At 6 h, 1 and 2 days after reperfusion, the TNF-alpha bioactivity in the myocardium was significantly higher in rats receiving LacZ plasmid than in sham-operated rats, whereas sTNFR1 plasmid significantly suppressed the increase in the TNF-alpha bioactivity. The sTNFR1 plasmid significantly reduced DNA fragmentation and caspase activity compared to the LacZ plasmid. Finally, the sTNFR1 expression-plasmid treatment significantly reduced the area of myocardial infarction at 2 days after ischemia/reperfusion compared to LacZ plasmid. In conclusion, the TNF-alpha bioactivity in the heart increased from the early stage of ischemia/reperfusion, and this increase was thought to contribute in part to the increased area of myocardial infarction. Suppression of TNF-alpha bioactivity with the sTNFR1 plasmid reduced the infarct size in AMI following ischemia and reperfusion.</description><identifier>ISSN: 0300-8177</identifier><identifier>EISSN: 1573-4919</identifier><identifier>DOI: 10.1023/b:mcbi.0000049149.03964.c9</identifier><identifier>PMID: 15646033</identifier><language>eng</language><publisher>Netherlands: Springer Nature B.V</publisher><subject>Animals ; Apoptosis ; Caspases - metabolism ; DNA Fragmentation ; Genetic Therapy ; Heart attacks ; Ischemia ; Male ; Myocardial infarction ; Myocardial Infarction - metabolism ; Myocardial Infarction - pathology ; Myocardial Infarction - therapy ; Myocardial Reperfusion Injury - metabolism ; Myocardial Reperfusion Injury - pathology ; Myocardial Reperfusion Injury - therapy ; Plasmids - administration & dosage ; Plasmids - genetics ; Protein Structure, Tertiary - genetics ; Rats ; Rats, Wistar ; Receptors, Tumor Necrosis Factor, Type I - genetics ; Rodents ; Tumor Necrosis Factor-alpha - antagonists & inhibitors ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Molecular and cellular biochemistry, 2004-11, Vol.266 (1-2), p.127-132</ispartof><rights>Kluwer Academic Publishers 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-6330f7fb207e40bee50f7d1055566551ef5a42820fdd419e6ec7befeb3c87f603</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15646033$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sugano, Masahiro</creatorcontrib><creatorcontrib>Hata, Tomoji</creatorcontrib><creatorcontrib>Tsuchida, Keiko</creatorcontrib><creatorcontrib>Suematsu, Nobuhiro</creatorcontrib><creatorcontrib>Oyama, Jun-Ichi</creatorcontrib><creatorcontrib>Satoh, Shinji</creatorcontrib><creatorcontrib>Makino, Naoki</creatorcontrib><title>Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats</title><title>Molecular and cellular biochemistry</title><addtitle>Mol Cell Biochem</addtitle><description>Apoptosis in the myocardium is linked to ischemia/reperfusion injury, and TNF-alpha induces apoptosis in cardiomyocytes. A significant amount of TNF-alpha is detected after ischemia and reperfusion. Soluble TNF-alpha receptor 1 (sTNFR1) is an extracellular domain of TNF-alpha receptor 1 and is an antagonist to TNF-alpha. In the present study, we examined the effects of sTNFR1 on infarct size in acute myocardial infarction (AMI) following ischemia/reperfusion. Male Wistar rats were subjected to left coronary artery (LCA) ligation. After 30 min of LCA occlusion, the temporary ligature on the LCA was released and blood flow was restored. Immediately after reperfusion, a total of 200 microg of sTNFR1 or LacZ plasmid was injected into three different sites of the left ventricular wall. At 6 h, 1 and 2 days after reperfusion, the TNF-alpha bioactivity in the myocardium was significantly higher in rats receiving LacZ plasmid than in sham-operated rats, whereas sTNFR1 plasmid significantly suppressed the increase in the TNF-alpha bioactivity. The sTNFR1 plasmid significantly reduced DNA fragmentation and caspase activity compared to the LacZ plasmid. Finally, the sTNFR1 expression-plasmid treatment significantly reduced the area of myocardial infarction at 2 days after ischemia/reperfusion compared to LacZ plasmid. In conclusion, the TNF-alpha bioactivity in the heart increased from the early stage of ischemia/reperfusion, and this increase was thought to contribute in part to the increased area of myocardial infarction. Suppression of TNF-alpha bioactivity with the sTNFR1 plasmid reduced the infarct size in AMI following ischemia and reperfusion.</description><subject>Animals</subject><subject>Apoptosis</subject><subject>Caspases - metabolism</subject><subject>DNA Fragmentation</subject><subject>Genetic Therapy</subject><subject>Heart attacks</subject><subject>Ischemia</subject><subject>Male</subject><subject>Myocardial infarction</subject><subject>Myocardial Infarction - metabolism</subject><subject>Myocardial Infarction - pathology</subject><subject>Myocardial Infarction - therapy</subject><subject>Myocardial Reperfusion Injury - metabolism</subject><subject>Myocardial Reperfusion Injury - pathology</subject><subject>Myocardial Reperfusion Injury - therapy</subject><subject>Plasmids - administration & dosage</subject><subject>Plasmids - genetics</subject><subject>Protein Structure, Tertiary - genetics</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, Tumor Necrosis Factor, Type I - genetics</subject><subject>Rodents</subject><subject>Tumor Necrosis Factor-alpha - antagonists & inhibitors</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0300-8177</issn><issn>1573-4919</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU1v1DAQhi0EokvhLyCrBzhl64ntOOmNrihUWuBSzpbjjFuvnDjYm6Ly6_HSlSpxgNFIoxk986WXkDNga2A1P-8vRtv7NTuY6EB0a8a7Rqxt94ysQCpelWr3nKwYZ6xqQakT8irnHWNQHF6SE5CNaBjnK3K_jdYEOmDw95geaHQ0x7D0AenN16vKhPnO0IQW531MFOgtTljyYbGYqZ-cSXZPs_-F1MUQ4k8_3VKf7R2O3pwnnDG5Jfs4FXa3lPl-osns82vywpmQ8c0xnpLvVx9vNp-r7bdP15sP28oKBfuq4Zw55fqaKRSsR5QlHYBJKZtGSkAnjajbmrlhENBhg1b16LDntlWufHhK3j_OnVP8sWDe67FchyGYCeOSdQtSciWbrpDv_kk2qoZadPy_YA3QqhZEAc_-AndxSVN5V5eNtVBK1gW6eIRsijkndHpOfjTpQQPTB7X1pf6yubzWT2rrP2pre7j57XHD0o84PLUe5eW_AZU4p48</recordid><startdate>200411</startdate><enddate>200411</enddate><creator>Sugano, Masahiro</creator><creator>Hata, Tomoji</creator><creator>Tsuchida, Keiko</creator><creator>Suematsu, Nobuhiro</creator><creator>Oyama, Jun-Ichi</creator><creator>Satoh, Shinji</creator><creator>Makino, Naoki</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200411</creationdate><title>Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats</title><author>Sugano, Masahiro ; Hata, Tomoji ; Tsuchida, Keiko ; Suematsu, Nobuhiro ; Oyama, Jun-Ichi ; Satoh, Shinji ; Makino, Naoki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-6330f7fb207e40bee50f7d1055566551ef5a42820fdd419e6ec7befeb3c87f603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Apoptosis</topic><topic>Caspases - metabolism</topic><topic>DNA Fragmentation</topic><topic>Genetic Therapy</topic><topic>Heart attacks</topic><topic>Ischemia</topic><topic>Male</topic><topic>Myocardial infarction</topic><topic>Myocardial Infarction - metabolism</topic><topic>Myocardial Infarction - pathology</topic><topic>Myocardial Infarction - therapy</topic><topic>Myocardial Reperfusion Injury - metabolism</topic><topic>Myocardial Reperfusion Injury - pathology</topic><topic>Myocardial Reperfusion Injury - therapy</topic><topic>Plasmids - administration & dosage</topic><topic>Plasmids - genetics</topic><topic>Protein Structure, Tertiary - genetics</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, Tumor Necrosis Factor, Type I - genetics</topic><topic>Rodents</topic><topic>Tumor Necrosis Factor-alpha - antagonists & inhibitors</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sugano, Masahiro</creatorcontrib><creatorcontrib>Hata, Tomoji</creatorcontrib><creatorcontrib>Tsuchida, Keiko</creatorcontrib><creatorcontrib>Suematsu, Nobuhiro</creatorcontrib><creatorcontrib>Oyama, Jun-Ichi</creatorcontrib><creatorcontrib>Satoh, Shinji</creatorcontrib><creatorcontrib>Makino, Naoki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular and cellular biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sugano, Masahiro</au><au>Hata, Tomoji</au><au>Tsuchida, Keiko</au><au>Suematsu, Nobuhiro</au><au>Oyama, Jun-Ichi</au><au>Satoh, Shinji</au><au>Makino, Naoki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats</atitle><jtitle>Molecular and cellular biochemistry</jtitle><addtitle>Mol Cell Biochem</addtitle><date>2004-11</date><risdate>2004</risdate><volume>266</volume><issue>1-2</issue><spage>127</spage><epage>132</epage><pages>127-132</pages><issn>0300-8177</issn><eissn>1573-4919</eissn><abstract>Apoptosis in the myocardium is linked to ischemia/reperfusion injury, and TNF-alpha induces apoptosis in cardiomyocytes. A significant amount of TNF-alpha is detected after ischemia and reperfusion. Soluble TNF-alpha receptor 1 (sTNFR1) is an extracellular domain of TNF-alpha receptor 1 and is an antagonist to TNF-alpha. In the present study, we examined the effects of sTNFR1 on infarct size in acute myocardial infarction (AMI) following ischemia/reperfusion. Male Wistar rats were subjected to left coronary artery (LCA) ligation. After 30 min of LCA occlusion, the temporary ligature on the LCA was released and blood flow was restored. Immediately after reperfusion, a total of 200 microg of sTNFR1 or LacZ plasmid was injected into three different sites of the left ventricular wall. At 6 h, 1 and 2 days after reperfusion, the TNF-alpha bioactivity in the myocardium was significantly higher in rats receiving LacZ plasmid than in sham-operated rats, whereas sTNFR1 plasmid significantly suppressed the increase in the TNF-alpha bioactivity. The sTNFR1 plasmid significantly reduced DNA fragmentation and caspase activity compared to the LacZ plasmid. Finally, the sTNFR1 expression-plasmid treatment significantly reduced the area of myocardial infarction at 2 days after ischemia/reperfusion compared to LacZ plasmid. In conclusion, the TNF-alpha bioactivity in the heart increased from the early stage of ischemia/reperfusion, and this increase was thought to contribute in part to the increased area of myocardial infarction. Suppression of TNF-alpha bioactivity with the sTNFR1 plasmid reduced the infarct size in AMI following ischemia and reperfusion.</abstract><cop>Netherlands</cop><pub>Springer Nature B.V</pub><pmid>15646033</pmid><doi>10.1023/b:mcbi.0000049149.03964.c9</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0300-8177 |
| ispartof | Molecular and cellular biochemistry, 2004-11, Vol.266 (1-2), p.127-132 |
| issn | 0300-8177 1573-4919 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_815537569 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Animals Apoptosis Caspases - metabolism DNA Fragmentation Genetic Therapy Heart attacks Ischemia Male Myocardial infarction Myocardial Infarction - metabolism Myocardial Infarction - pathology Myocardial Infarction - therapy Myocardial Reperfusion Injury - metabolism Myocardial Reperfusion Injury - pathology Myocardial Reperfusion Injury - therapy Plasmids - administration & dosage Plasmids - genetics Protein Structure, Tertiary - genetics Rats Rats, Wistar Receptors, Tumor Necrosis Factor, Type I - genetics Rodents Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumor Necrosis Factor-alpha - metabolism |
| title | Local delivery of soluble TNF-alpha receptor 1 gene reduces infarct size following ischemia/reperfusion injury in rats |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T20%3A31%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Local%20delivery%20of%20soluble%20TNF-alpha%20receptor%201%20gene%20reduces%20infarct%20size%20following%20ischemia/reperfusion%20injury%20in%20rats&rft.jtitle=Molecular%20and%20cellular%20biochemistry&rft.au=Sugano,%20Masahiro&rft.date=2004-11&rft.volume=266&rft.issue=1-2&rft.spage=127&rft.epage=132&rft.pages=127-132&rft.issn=0300-8177&rft.eissn=1573-4919&rft_id=info:doi/10.1023/b:mcbi.0000049149.03964.c9&rft_dat=%3Cproquest_cross%3E815537569%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=756247752&rft_id=info:pmid/15646033&rfr_iscdi=true |